| Truc Nguyen, FNP-C | |
|
10425 Sw 130th Ave, Beaverton, OR 97008-8169 | |
| (503) 841-0520 | |
| Not Available |
| Full Name | Truc Nguyen |
|---|---|
| Gender | Female |
| Speciality | Nurse Practitioner |
| Experience | 3 Years |
| Location | 10425 Sw 130th Ave, Beaverton, Oregon |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1437813409 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 363LF0000X | Nurse Practitioner - Family | 202111406NP-PP (Oregon) | Primary |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Inovia Llc | 2860592854 | 13 |
News Archive
The Pulitzer Center on Crisis Reporting "launched its collaborative reproductive health reporting project last week at the International Family Planning Conference (IFPC) in Dakar, Senegal," according to a post on the Center's website.
Researchers at Geisinger Health System are studying how genes may affect a patient's ability to lose weight following bariatric surgery. Highlighted in the journal Obesity, the study found that several genes that promote obesity may also result in inferior weight loss outcomes after gastric bypass surgery.
Patients with the most severe and dangerous form of chronic anorexia are more likely to make a significant improvement towards recovery and stay in therapy if traditional psychological treatments are re-focused from weight gain to quality of life issues.
The prevalence of a certain form of drug-resistant bacteria, called multidrug-resistant gram-negative (MDRGN) organisms, far surpassed that of two other common antimicrobial-resistant infections in long-term care facilities, according to a study conducted by researchers at Hebrew SeniorLife's Institute for Aging Research.
Progenics Pharmaceuticals, Inc. today announced that the U.S. Food and Drug Administration (FDA), along with the European Medicines Agency (EMA) of the European Union (E.U.) and Health Canada, the Canadian Regulatory Agency, have each approved single-use, pre-filled syringes of RELISTOR® (methylnaltrexone bromide) Subcutaneous Injection for use in their respective territories. These pre-filled syringes provide a simplified dosing option for the treatment of opioid-induced constipation (OIC) in palliative-care patients with advanced illness.
› Verified 2 days ago
| Entity Name | Inovia Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1376753442 PECOS PAC ID: 2860592854 Enrollment ID: O20070703000750 |
News Archive
The Pulitzer Center on Crisis Reporting "launched its collaborative reproductive health reporting project last week at the International Family Planning Conference (IFPC) in Dakar, Senegal," according to a post on the Center's website.
Researchers at Geisinger Health System are studying how genes may affect a patient's ability to lose weight following bariatric surgery. Highlighted in the journal Obesity, the study found that several genes that promote obesity may also result in inferior weight loss outcomes after gastric bypass surgery.
Patients with the most severe and dangerous form of chronic anorexia are more likely to make a significant improvement towards recovery and stay in therapy if traditional psychological treatments are re-focused from weight gain to quality of life issues.
The prevalence of a certain form of drug-resistant bacteria, called multidrug-resistant gram-negative (MDRGN) organisms, far surpassed that of two other common antimicrobial-resistant infections in long-term care facilities, according to a study conducted by researchers at Hebrew SeniorLife's Institute for Aging Research.
Progenics Pharmaceuticals, Inc. today announced that the U.S. Food and Drug Administration (FDA), along with the European Medicines Agency (EMA) of the European Union (E.U.) and Health Canada, the Canadian Regulatory Agency, have each approved single-use, pre-filled syringes of RELISTOR® (methylnaltrexone bromide) Subcutaneous Injection for use in their respective territories. These pre-filled syringes provide a simplified dosing option for the treatment of opioid-induced constipation (OIC) in palliative-care patients with advanced illness.
› Verified 2 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Truc Nguyen, FNP-C 10425 Sw 130th Ave, Beaverton, OR 97008-8169 Ph: () - | Truc Nguyen, FNP-C 10425 Sw 130th Ave, Beaverton, OR 97008-8169 Ph: (503) 841-0520 |
News Archive
The Pulitzer Center on Crisis Reporting "launched its collaborative reproductive health reporting project last week at the International Family Planning Conference (IFPC) in Dakar, Senegal," according to a post on the Center's website.
Researchers at Geisinger Health System are studying how genes may affect a patient's ability to lose weight following bariatric surgery. Highlighted in the journal Obesity, the study found that several genes that promote obesity may also result in inferior weight loss outcomes after gastric bypass surgery.
Patients with the most severe and dangerous form of chronic anorexia are more likely to make a significant improvement towards recovery and stay in therapy if traditional psychological treatments are re-focused from weight gain to quality of life issues.
The prevalence of a certain form of drug-resistant bacteria, called multidrug-resistant gram-negative (MDRGN) organisms, far surpassed that of two other common antimicrobial-resistant infections in long-term care facilities, according to a study conducted by researchers at Hebrew SeniorLife's Institute for Aging Research.
Progenics Pharmaceuticals, Inc. today announced that the U.S. Food and Drug Administration (FDA), along with the European Medicines Agency (EMA) of the European Union (E.U.) and Health Canada, the Canadian Regulatory Agency, have each approved single-use, pre-filled syringes of RELISTOR® (methylnaltrexone bromide) Subcutaneous Injection for use in their respective territories. These pre-filled syringes provide a simplified dosing option for the treatment of opioid-induced constipation (OIC) in palliative-care patients with advanced illness.
› Verified 2 days ago
Amanda Hunt, NP Nurse Practitioner Medicare: Medicare Enrolled Practice Location: 4145 Sw Watson Ave Ste 350, Beaverton, OR 97005 Phone: 866-849-0692 | |
Mrs. Sherry Diane Davidson, PMHNP Nurse Practitioner Medicare: Not Enrolled in Medicare Practice Location: 10700 Sw Beaverton-hillsdale Hwy, Park Plaza West Bld 3 Suite 547, Beaverton, OR 97005 Phone: 503-643-0428 | |
Dr. Kathleen Anne Roberts, DNP Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 2725 Sw Cedar Hills Blvd Ste 200, Beaverton, OR 97005 Phone: 503-352-6000 Fax: 503-352-6081 | |
Sherry L Sweeney, CPNP Nurse Practitioner Medicare: Medicare Enrolled Practice Location: 15455 Nw Greenbrier Pkwy, Suite 111, Beaverton, OR 97006 Phone: 503-531-2323 | |
Ms. Hillary L Corson, APRN, PMHNP-BC Nurse Practitioner Medicare: Not Enrolled in Medicare Practice Location: 6600 Sw 105th Ave Ste 120, Beaverton, OR 97008 Phone: 971-245-1332 Fax: 503-641-5179 | |
Ms. Victoria Lynn Keyton, NP Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 4510 Sw Hall Blvd, Beaverton, OR 97005 Phone: 503-644-1171 Fax: 503-643-7443 | |
Margie Nielsen, DNP, FNP-BC Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 15950 Sw Millikan Way, Beaverton, OR 97003 Phone: 503-646-0161 Fax: 503-643-7459 |